Literature DB >> 34455469

When should we consider chronic patients as non-responders to monoclonal antibodies targeting the CGRP pathway?

Claudia Altamura1, Sabina Cevoli2, Nicoletta Brunelli1, Cinzia Aurilia3, Luisa Fofi3, Gabriella Egeo3, Piero Barbanti3,4, Fabrizio Vernieri5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34455469     DOI： 10.1007/s00415-021-10772-7

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  2 in total

Review 1.  Migraine: epidemiology and systems of care.

Authors:  Messoud Ashina; Zaza Katsarava; Thien Phu Do; Dawn C Buse; Patricia Pozo-Rosich; Aynur Özge; Abouch V Krymchantowski; Elena R Lebedeva; Krishnamurthy Ravishankar; Shengyuan Yu; Simona Sacco; Sait Ashina; Samaira Younis; Timothy J Steiner; Richard B Lipton
Journal:  Lancet       Date:  2021-03-25       Impact factor: 79.321

2.  Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study).

Authors:  Fabrizio Vernieri; Claudia Altamura; Nicoletta Brunelli; Carmelina Maria Costa; Cinzia Aurilia; Gabriella Egeo; Luisa Fofi; Valentina Favoni; Giulia Pierangeli; Carlo Lovati; Marco Aguggia; Florindo d'Onofrio; Alberto Doretti; Paola Di Fiore; Cinzia Finocchi; Renata Rao; Francesco Bono; Angelo Ranieri; Maria Albanese; Sabina Cevoli; Piero Barbanti
Journal:  J Headache Pain       Date:  2021-05-03       Impact factor: 7.277
  2 in total
  2 in total

1.  Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study.

Authors:  Piero Barbanti; Claudia Altamura; Fabrizio Vernieri; Nicoletta Brunelli; Roberta Messina; Carmelina Maria Costa; Bruno Colombo; Paola Torelli; Simone Quintana; Sabina Cevoli; Valentina Favoni; Florindo d'Onofrio; Gabriella Egeo; Renata Rao; Massimo Filippi
Journal:  J Headache Pain       Date:  2021-12-18       Impact factor: 7.277

2.  Clinical Management of Migraine.

Authors:  Maria Albanese
Journal:  J Clin Med       Date:  2022-09-04       Impact factor: 4.964
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.